MARKET

CTSO

CTSO

Cytosorbents Corp
NASDAQ
0.6300
+0.0210
+3.45%
After Hours: 0.6300 0 0.00% 16:10 05/11 EDT
OPEN
0.6100
PREV CLOSE
0.6090
HIGH
0.6300
LOW
0.6100
VOLUME
62.59K
TURNOVER
--
52 WEEK HIGH
1.390
52 WEEK LOW
0.4992
MARKET CAP
39.57M
P/E (TTM)
-4.7836
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at CTSO last week (0504-0508)?
Weekly Report · 13h ago
Weekly Report: what happened at CTSO last week (0427-0501)?
Weekly Report · 05/04 10:18
CytoSorbents to report first-quarter results after market close May 13
PUBT · 04/30 11:08
Weekly Report: what happened at CTSO last week (0420-0424)?
Weekly Report · 04/27 10:20
Weekly Report: what happened at CTSO last week (0413-0417)?
Weekly Report · 04/20 10:16
Weekly Report: what happened at CTSO last week (0406-0410)?
Weekly Report · 04/13 10:20
Weekly Report: what happened at CTSO last week (0330-0403)?
Weekly Report · 04/06 10:21
CytoSorbents Receives Nasdaq Extension to Regain Compliance
TipRanks · 04/02 11:42
More
About CTSO
CytoSorbents Corporation is engaged in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery through blood purification. The Company’s blood purification technologies are based on biocompatible, highly porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. Its lead product, CytoSorb, is an extracorporeal blood purification cartridge to reduce cytokine storms in common critical illnesses that can lead to massive inflammation, organ failure and patient death. Its products also include ECOS-300CY, VetResQ, DrugSorb-ATR, and PuriFi. DrugSorb-ATR is an investigational device that uses equivalent polymer technology to CytoSorb to address a large unmet need for blood thinner reversal in cardiothoracic surgery. ECOS-300CY is used to reduce cytokines and other inflammatory mediators when used in an ex vivo organ perfusion system.

Webull offers Cytosorbents Corp stock information, including NASDAQ: CTSO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CTSO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CTSO stock methods without spending real money on the virtual paper trading platform.